ABOUT DANAHER LIFE SCIENCES
Every day, scientists around the world are dedicated to unraveling the mysteries of disease, discovering novel therapies and vaccines, and conducting crucial drug testing. At Danaher Life Sciences, a collection of businesses within Danaher Corporation, we play a pivotal role in facilitating these cutting-edge scientific endeavors. Our comprehensive capabilities go beyond research, enabling us to drive the development of innovative biopharmaceuticals, revolutionary cell and gene therapies, and other breakthrough treatments that propel patient health forward and enhance treatment outcomes.


FEATURED ARTICLES
-
Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.
-
Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.
-
Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.
-
Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.
-
Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.
-
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
-
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Evolving regulations are shaping the adoption of NGS for biosafety and product characterization. Learn what teams must consider when validating modern sequencing assays within GMP‑regulated environments.
-
Cultivate oxygen-sensitive probiotics with precision using real-time monitoring, microfluidic feeding, and pH control for reproducible growth and optimized microbiome and fermentation research.
-
Discover how oxygen-enriched conditions and smart feeding strategies boost microbial growth. Prevent oxygen limitation, improve productivity, and maintain control for high-density bioprocessing success.
-
Unlock efficient microalgae cultivation with precise lighting and real-time insights. Explore ways to boost biomass, optimize growth, and accelerate sustainable bioenergy and bioproduct innovation.
-
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
-
View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.
-
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
Resolve monomers from dimers across AAV serotypes with a breakthrough solution that cuts sample use by up to 90%, accelerates development, and reduces costs—transforming gene therapy workflows.
-
Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.
CONTACT INFORMATION
Danaher Life Sciences
500 Old Connecticut Path
Framingham, MA 01701
UNITED STATES